Literature DB >> 22497435

Insulin glargine use and short-term incidence of breast cancer - a four-year population-based observation.

Rickard Ljung, Mats Talbäck, Bengt Haglund, Junmei Miao Jonasson, Soffia Gudbjörnsdòttir, Gunnar Steineck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22497435     DOI： 10.3109/0284186X.2011.624118

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  10 in total

Review 1.  The links between insulin resistance, diabetes, and cancer.

Authors:  Etan Orgel; Steven D Mittelman
Journal:  Curr Diab Rep       Date:  2013-04       Impact factor: 4.810

Review 2.  Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.

Authors:  Emily Jane Gallagher; Derek LeRoith
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

3.  Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes.

Authors:  Laurel A Habel; Kim N Danforth; Charles P Quesenberry; Angela Capra; Stephen K Van Den Eeden; Noel S Weiss; Assiamira Ferrara
Journal:  Diabetes Care       Date:  2013-10-29       Impact factor: 19.112

Review 4.  The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms.

Authors:  Kyong Hye Joung; Jae-Wook Jeong; Bon Jeong Ku
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

Review 5.  Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes.

Authors:  Joshua J Joseph; Thomas W Donner
Journal:  Vasc Health Risk Manag       Date:  2015-01-28

6.  Does long-term use of antidiabetic drugs changes cancer risk?

Authors:  Yi-Chun Liu; Phung-Anh Nguyen; Ayesha Humayun; Shuo-Chen Chien; Hsuan-Chia Yang; Rahma Novita Asdary; Shabbir Syed-Abdul; Min-Huei Hsu; Max Moldovan; Yun Yen; Yu-Chuan Jack Li; Wen-Shan Jian; Usman Iqbal
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

7.  A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time.

Authors:  Hulda Hrund Bjornsdottir; Araz Rawshani; Aidin Rawshani; Stefan Franzén; Ann-Marie Svensson; Naveed Sattar; Soffia Gudbjörnsdottir
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

Review 8.  Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links.

Authors:  Ya Wang; Xinling Zeng; Jie Tan; Yi Xu; Cunjian Yi
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

Review 9.  Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.

Authors:  Oystein Karlstad; Jacob Starup-Linde; Peter Vestergaard; Vidar Hjellvik; Marloes T Bazelier; Marjanka K Schmidt; Morten Andersen; Anssi Auvinen; Jari Haukka; Kari Furu; Frank de Vries; Marie L De Bruin
Journal:  Curr Drug Saf       Date:  2013-11

10.  Cancer incidence among those initiating insulin therapy with glargine versus human NPH insulin.

Authors:  Til Stürmer; M Alison Marquis; Haibo Zhou; James B Meigs; Soo Lim; Lawrence Blonde; Eileen Macdonald; Ray Wang; Lisa M Lavange; Virginia Pate; John B Buse
Journal:  Diabetes Care       Date:  2013-07-22       Impact factor: 19.112
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.